Pegylated interferon alfa-2b is a treatment for hepatitis C developed by Schering-
Plough, brand name is PegIntron. It was approved in January 2001. It has also ...
Jun 15, 2016 ... Peginterferon alfa-2b may cause or worsen the following conditions that may be
serious or cause death: infections; mental illness including ...
Medscape - Dosing for PEG Intron, Sylatron (peginterferon-alfa-2b), frequency-
based adverse effects, comprehensive interactions, contraindications, pregnancy
PEGINTRON safely and effectively. See full prescribing information for
PEGINTRON. PEGINTRON® (peginterferon alfa-2b) injection, for subcutaneous
Peginterferon alfa-2b is an antiviral prescription medicine approved by the U.S.
Food and Drug Administration (FDA) for the treatment of chronic hepatitis C virus
May 9, 2013 ... This page contains brief information about peginterferon alfa-2b and a collection
of links to more information about the use of this drug, ...
Sep 26, 2003 ... PEG-Intron<sup>TM</sup>, peginterferon alfa-2b, Powder for Injection, is a covalent
conjugate of recombinant alfa interferon with monomethoxy ...
Jun 13, 2005 ... The specific activity of peginterferon alfa-2b is approximately 0.7 x 108 IU/mg
protein. Interferon alfa-2b is a water-soluble protein with a ...
Aug 6, 2009 ... Treatment guidelines recommend the use of peginterferon alfa-2b or
peginterferon alfa-2a in combination with ribavirin for chronic hepatitis C ...
Each vial contains 50 micrograms of peginterferon alfa-2b as measured on a ....
studied with pegylated interferon alfa-2b and ribavirin combination therapy.